{
    "Overall_score": {
        "Correlation": 8,
        "Sentiment": 6,
        "Importance": 7,
        "Impact": 7,
        "Duration": 5,
        "Virality": 4,
        "Source_Score": 6,
        "Specificity": 7,
        "Sector_Spread": 6,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "Subscribers saw our Penny Stock Picks gain over 4,000% this year! Subscribe Today: http://t.co/4wK9alr02J $ACT $VRX $ABBV",
            "Correlation": 4,
            "Sentiment": 9,
            "Importance": 3,
            "Impact": 3,
            "Duration": 2,
            "Virality": 5,
            "Source_Score": 3,
            "Specificity": 4,
            "Sector_Spread": 5,
            "Tech_Mentions": 1
        },
        {
            "News_content": "RT @OpenOutcrier: $SPHG Hearing $ABBV considering a higher offer for Shire",
            "Correlation": 8,
            "Sentiment": 7,
            "Importance": 7,
            "Impact": 6,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 5,
            "Specificity": 7,
            "Sector_Spread": 6,
            "Tech_Mentions": 1
        },
        {
            "News_content": "AbbVie says Shire has spurned three buyout offers, won't rule out new bid. http://t.co/fRi91VqRJy by @JohnCFierce $ABBV $SHPG",
            "Correlation": 9,
            "Sentiment": 5,
            "Importance": 8,
            "Impact": 7,
            "Duration": 6,
            "Virality": 4,
            "Source_Score": 7,
            "Specificity": 9,
            "Sector_Spread": 7,
            "Tech_Mentions": 1
        },
        {
            "News_content": "AbbVie's outperform rating reiterated at Credit Suisse. $60.00 PT. http://t.co/y32BeUuAun $ABBV #ABBV",
            "Correlation": 8,
            "Sentiment": 7,
            "Importance": 6,
            "Impact": 5,
            "Duration": 3,
            "Virality": 2,
            "Source_Score": 8,
            "Specificity": 8,
            "Sector_Spread": 5,
            "Tech_Mentions": 2
        },
        {
            "News_content": "RT @SeekingAlpha: Fire Up The Immuno-Oncology Powerhouses: John McCamant http://t.co/mBdvMy0wMa $ABBV $ANTH $INCY $NVAX $PCYC",
            "Correlation": 6,
            "Sentiment": 7,
            "Importance": 5,
            "Impact": 4,
            "Duration": 3,
            "Virality": 3,
            "Source_Score": 7,
            "Specificity": 6,
            "Sector_Spread": 8,
            "Tech_Mentions": 1
        },
        {
            "News_content": "Drug maker Shire rejects offer from AbbVie.. http://t.co/N6szm4JHRX $ABBV #biotech #stocks",
            "Correlation": 9,
            "Sentiment": 4,
            "Importance": 7,
            "Impact": 6,
            "Duration": 5,
            "Virality": 3,
            "Source_Score": 6,
            "Specificity": 8,
            "Sector_Spread": 6,
            "Tech_Mentions": 1
        },
        {
            "News_content": "RT @fwpharma: ICYMI: AbbVie says offer to acquire Shire for around $46 billion rejected http://t.co/Szk3LzwJgi $ABBV $SHP #pharma",
            "Correlation": 8,
            "Sentiment": 5,
            "Importance": 7,
            "Impact": 6,
            "Duration": 5,
            "Virality": 3,
            "Source_Score": 6,
            "Specificity": 8,
            "Sector_Spread": 6,
            "Tech_Mentions": 1
        },
        {
            "News_content": "RT @OpeningBellFBN: @EliLillyCo John Lechleiter tells @MariaBartiromo tax inversion will not drive deals for the company $ABBV $PFE",
            "Correlation": 7,
            "Sentiment": 6,
            "Importance": 6,
            "Impact": 5,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 7,
            "Specificity": 7,
            "Sector_Spread": 5,
            "Tech_Mentions": 1
        },
        {
            "News_content": "$ABBV - Shire rejects AbbVie takeover approaches -> http://t.co/EqRZDUwWkH #stock #stocks #stockaction",
            "Correlation": 9,
            "Sentiment": 4,
            "Importance": 7,
            "Impact": 6,
            "Duration": 5,
            "Virality": 3,
            "Source_Score": 6,
            "Specificity": 8,
            "Sector_Spread": 6,
            "Tech_Mentions": 1
        },
        {
            "News_content": "$ABBV - Shire props up European shares on bid hopes -> http://t.co/qaGZJuCWjc #stock #stocks #stockaction",
            "Correlation": 8,
            "Sentiment": 6,
            "Importance": 6,
            "Impact": 5,
            "Duration": 4,
            "Virality": 2,
            "Source_Score": 6,
            "Specificity": 7,
            "Sector_Spread": 5,
            "Tech_Mentions": 1
        },
        {
            "News_content": "$ABBV critics 'straw man' argument: Humira patents begin expiry in '16, so obviously Humira revenues decline significantly... false",
            "Correlation": 8,
            "Sentiment": 5,
            "Importance": 7,
            "Impact": 6,
            "Duration": 6,
            "Virality": 2,
            "Source_Score": 7,
            "Specificity": 8,
            "Sector_Spread": 5,
            "Tech_Mentions": 2
        }
    ]
}